96 related articles for article (PubMed ID: 7972217)
1. Differentiation-inducing agents stably convert human neuroblastoma I-type cells to neuroblastic (N) or nonneuronal (S) neural crest cells.
Ross RA; Spengler BA; Rettig WJ; Biedler JL
Prog Clin Biol Res; 1994; 385():253-9. PubMed ID: 7972217
[No Abstract] [Full Text] [Related]
2. Human neuroblastoma I-type cells are malignant neural crest stem cells.
Ross RA; Spengler BA; Domènech C; Porubcin M; Rettig WJ; Biedler JL
Cell Growth Differ; 1995 Apr; 6(4):449-56. PubMed ID: 7794812
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM
Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
5. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells.
Ross RA; Hein AM; Braca JA; Spengler BA; Biedler JL; Scammell JG
Oncol Res; 2002; 13(2):87-94. PubMed ID: 12392156
[TBL] [Abstract][Full Text] [Related]
7. Multipotent capacity of morphologically intermediate (I-type) human neuroblastoma cells after treatment with differentiation-inducing drugs.
Ross RA; Bossart E; Spengler BA; Biedler JL
Prog Clin Biol Res; 1991; 366():193-201. PubMed ID: 1676844
[No Abstract] [Full Text] [Related]
8. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants.
Rettig WJ; Spengler BA; Chesa PG; Old LJ; Biedler JL
Cancer Res; 1987 Mar; 47(5):1383-9. PubMed ID: 3028608
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cell surface antigens accompanies morphological differentiation of human neuroblastoma cell lines.
Reynolds CP; Maples J
Prog Clin Biol Res; 1985; 175():13-37. PubMed ID: 2986170
[No Abstract] [Full Text] [Related]
10. Transforming growth factor-beta 1 differentially regulates proliferation, morphology, and extracellular matrix expression by three neural crest-derived neuroblastoma cell lines.
Rogers SL; Cutts JL; Gegick PJ; McGuire PG; Rosenberger C; Krisinski S
Exp Cell Res; 1994 Apr; 211(2):252-62. PubMed ID: 8143771
[TBL] [Abstract][Full Text] [Related]
11. NUB-7: a stable I-type human neuroblastoma cell line inducible along N- and S-type cell lineages.
Dimitroulakos J; Squire J; Pawlin G; Yeger H
Cell Growth Differ; 1994 Apr; 5(4):373-84. PubMed ID: 8043511
[TBL] [Abstract][Full Text] [Related]
12. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells.
Sumantran VN; Brederlau A; Funa K
Anticancer Res; 2003; 23(2B):1297-303. PubMed ID: 12820386
[TBL] [Abstract][Full Text] [Related]
13. Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model.
Rogers DA; Schor NF
Exp Cell Res; 2013 Mar; 319(5):660-9. PubMed ID: 23333500
[TBL] [Abstract][Full Text] [Related]
14. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
15. Morphologic conversion of a neuroblastoma-derived cell line by E6-mediated p53 degradation.
Gaitonde SV; Qi W; Falsey RR; Sidell N; Martinez JD
Cell Growth Differ; 2001 Jan; 12(1):19-27. PubMed ID: 11205742
[TBL] [Abstract][Full Text] [Related]
16. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
17. N-Myc overexpression leads to decreased beta1 integrin expression and increased apoptosis in human neuroblastoma cells.
van Golen CM; Soules ME; Grauman AR; Feldman EL
Oncogene; 2003 May; 22(17):2664-73. PubMed ID: 12730680
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells.
Acosta S; Lavarino C; Paris R; Garcia I; de Torres C; Rodríguez E; Beleta H; Mora J
BMC Dev Biol; 2009 Feb; 9():12. PubMed ID: 19216736
[TBL] [Abstract][Full Text] [Related]
19. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
Chen J; Liu T; Zhe X; Jiang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):197-202. PubMed ID: 12569653
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines.
Ichimiya S; Nimura Y; Seki N; Ozaki T; Nagase T; Nakagawara A
Med Pediatr Oncol; 2001 Jan; 36(1):132-4. PubMed ID: 11464865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
